Ramdevbaba Solvent Ltd
Founded in 2008, Ramdevbaba Solvent Limited produces and distributes physically refined rice bran oil.[1]
- Market Cap ₹ 256 Cr.
- Current Price ₹ 112
- High / Low ₹ 150 / 84.5
- Stock P/E 17.0
- Book Value ₹ 66.3
- Dividend Yield 0.00 %
- ROCE 13.1 %
- ROE 13.4 %
- Face Value ₹ 10.0
Pros
- Company has delivered good profit growth of 24.2% CAGR over last 5 years
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Promoter holding has decreased over last quarter: -2.13%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Half Yearly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2013 | Mar 2014 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|
| 105 | 124 | 349 | 424 | 583 | 698 | 686 | 928 | |
| 104 | 123 | 337 | 410 | 566 | 679 | 661 | 903 | |
| Operating Profit | 1 | 1 | 12 | 13 | 17 | 19 | 25 | 26 |
| OPM % | 1% | 1% | 3% | 3% | 3% | 3% | 4% | 3% |
| 0 | 0 | 1 | 2 | 2 | 9 | 7 | 7 | |
| Interest | 0 | 0 | 3 | 4 | 5 | 6 | 10 | 8 |
| Depreciation | 0 | 0 | 3 | 4 | 5 | 2 | 4 | 5 |
| Profit before tax | 1 | 1 | 6 | 7 | 9 | 19 | 18 | 20 |
| Tax % | 0% | 0% | 19% | 19% | 22% | 24% | 26% | 25% |
| 1 | 1 | 5 | 6 | 7 | 15 | 13 | 15 | |
| EPS in Rs | 27.64 | 19.79 | 110.75 | 125.57 | 145.19 | 320.25 | 8.04 | 6.57 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 22% |
| 3 Years: | 17% |
| TTM: | 35% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 24% |
| 3 Years: | 31% |
| TTM: | 15% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | 8% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 20% |
| Last Year: | 13% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2013 | Mar 2014 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3 | 4 | 5 | 5 | 5 | 16 | 23 | |
| Reserves | 1 | 3 | 24 | 31 | 43 | 57 | 129 | |
| 14 | 12 | 45 | 65 | 99 | 111 | 94 | ||
| 6 | 9 | 26 | 28 | 44 | 46 | 43 | ||
| Total Liabilities | 24 | 27 | 99 | 129 | 191 | 229 | 289 | |
| 14 | 12 | 39 | 40 | 62 | 94 | 96 | ||
| CWIP | 0 | 0 | 0 | 12 | 28 | 3 | 13 | |
| Investments | 0 | 0 | 0 | 0 | 0 | 8 | 14 | |
| 10 | 14 | 60 | 77 | 101 | 125 | 165 | ||
| Total Assets | 24 | 27 | 99 | 129 | 191 | 229 | 289 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2013 | Mar 2014 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|
| 4 | 3 | -3 | 3 | 11 | 5 | -12 | ||
| -8 | -1 | -3 | -18 | -39 | -19 | -24 | ||
| 3 | -2 | 6 | 15 | 28 | 14 | 39 | ||
| Net Cash Flow | 0 | 1 | -0 | -0 | 0 | -0 | 3 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2013 | Mar 2014 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 11 | 21 | 16 | 17 | 20 | 22 | 13 | |
| Inventory Days | 39 | 26 | 29 | 40 | 35 | |||
| Days Payable | 16 | 16 | 19 | 20 | 10 | |||
| Cash Conversion Cycle | 11 | 21 | 39 | 28 | 31 | 41 | 37 | |
| Working Capital Days | 12 | 12 | 28 | 30 | 30 | 42 | 35 | |
| ROCE % | 4% | 16% | 20% | 17% | 13% |
Documents
Announcements
-
Updates
4 June 2025 - No deviation in utilization of Rs. 44.62 Cr IPO and Rs. 26.04 Cr preferential issue proceeds.
-
Structural Digital Database
28 May 2025 - Submission of SEBI-mandated SDD Compliance Certificate for FY ended March 31, 2025, with no non-compliances.
-
Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent
27 May 2025 - RAMDEVBABA SOLVENT LIMITED has informed about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent
-
Statement of deviation(s) or variation(s) under Reg. 32
27 May 2025 - No deviation in utilization of Rs. 44.62 Cr IPO and Rs. 26.04 Cr preferential issue proceeds.
-
Outcome of Board Meeting
27 May 2025 - Audited FY25 financial results approved; auditor appointments and IPO/preferential share allotments disclosed.
Business Segments
A) Third Party Manufacturing[1] The Company manufactures, distributes, markets, and sells rice bran oil to FMCG companies like Mother Dairy Fruit & Vegetable Private Limited, Marico Limited, and Empire Spices and Foods Ltd.